Extraordinary efforts by scientists, regulators, and developers enabled the European Medicines Agency (EMA) to recommend the first EU conditional marketing authorisation (CMA) for the BioNTech COVID-19 mRNA vaccine (nucleoside-modified) BNT162b2 (Comirnaty)1 some 9 months after the COVID-19 pandemic was declared. More @Wikipedia
Get the latest news about Ema European Medicines Agency from the top news sites, aggregators and blogs. Also included are videos, photos, and websites related to Ema European Medicines Agency .
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.